Dec 31, 2023

Entrada Therapeutics Q4 2023 Earnings Report

Total Revenue
$41.8M
EPS
-$0.29
Previous year: -$0.79
-63.3%
Gross Profit
$41.1M
Cash and Equivalents
$352M
Previous year: $45.2M
+679.4%
Free Cash Flow
-$4.99M
Previous year: -$28M
-82.2%
Total Assets
$469M
Previous year: $252M
+86.1%

Entrada Therapeutics

Entrada Therapeutics